Transforming growth factor-β1 bioassay involving matrix metalloproteinase-2 induction

Journal of Interferon and Cytokine Research

Volumn 30, Issue 9, 2010, Pages 667-672

  Kim, Gi Hyun ^a,b   Kang, So Young ^a   Kwak, Ho Jung ^a   Baek, Kyung Min ^a   Hong, Seung Hwa ^a   Lee, Hwa Jeong ^b   Sohn, Yeo Won ^a  

^a Korea Food and Drug Administration   (South Korea)

^b Ewha Womans University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLERA TOXIN; DNA; EPIDERMAL GROWTH FACTOR; GELATIN; GELATINASE A; INSULIN; LUCIFERASE; RECOMBINANT GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; TRANSFORMING GROWTH FACTOR BETA1;

ARTICLE; BIOASSAY; CELL PROLIFERATION; COMPARATIVE STUDY; CONTROLLED STUDY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; REPORTER GENE; REPRODUCIBILITY; TRANSCRIPTION REGULATION; ZYMOGRAPHY;

BIOLOGICAL ASSAY; CELL LINE; CLONING, MOLECULAR; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; ENZYME INDUCTION; FEMALE; GENES, REPORTER; HUMANS; LUCIFERASES; LUMINESCENCE; MAMMARY GLANDS, HUMAN; MATRIX METALLOPROTEINASE 2; PROMOTER REGIONS, GENETIC; REPRODUCIBILITY OF RESULTS; TRANSFORMING GROWTH FACTOR BETA1;

EID: 77956561630     PISSN: 10799907     EISSN: None     Source Type: Journal    
DOI: 10.1089/jir.2009.0058     Document Type: Article

References (23)

1. Assoian RK, Komoriya A, Meyers CA, Miller DM, Sporn MB. 1983. Transforming growth factor-beta in human platelets. Identification of a major storage site, purification, and characterization. J Biol Chem 258(11):7155-7160.
2. Coussens LM, Fingleton B, Matrisian LM. 2002. Matrix Me-talloproteinase inhibitors and cancer: trials and tribulations. Science 29:295:2387-2392.
3. Curran S, Murray GI. 2000. Matrix metalloproteinases: molecular aspects of their roles in tumor invasion and metastasis. Eur J Cancer 36:1621-1630.
4. De Martin R, Haendler B, Hofer-Warbinek R, Gaugitsch H, Wrann M, Schlüsener H, Seifert JM, Bodmer S, Fontana A, and Hofer E. 1987. Complementary DNA for human glio-blastoma-derived T cell suppressor factor, a novel member of the transforming growth factor-b gene family. EMBO 6(12): 3673-3677.
5. Derynck R, Jarrett JA, Chen EY, Eaton DH, Bell JR, Assoian RK, Roberts AB, Sporn MB, Goeddel DV. 1985. Human transforming growth factor-b cDNA sequence and expression in tumor cell lines. Nature 316:701-705.
6. Derynck R, Lindquist PB, Lee A, Wen D, Ramm J, Graycar JL, Rhee L, Mason AJ, Miller DA, Coffey RJ. 1988. A new type of transforming growth factor-b, TGF-b3. EMBO 7:3737-3743.
7. Farmer JT, Weigent DA. 2006. TGF-b1 expression in EL4 lym-phoma cells overexpressing growth hormone. Cell Immunol 240:22-30.
8. Gail EMM, Kjetil A, Sarah EG, Martin K, Jack G. 2006. The transforming growth factor-beta (TGF-b) family and pulmonary fibrosis. Drug Discov Today Dis Mech 3(1):99-103.
9. Gerard CB, William PS, Harvey FL. 2000. Role of transforming growth factor b in human disease. N Engl J Med 342(18):1350-1358.
10. Graycar JL, Miller DA, Arrick BA, Lyons RM, Moses HL, Derynck R. 1989. Human transforming growth factor-beta 3: recombinant expression, purification, and biological activities in comparison with transforming growth factors-beta 1 and-beta 2. Mol Endocrinol 3(12):1977-1986.
11. Hanahan D, Weinberg RA. 2000. The hallmarks of cancer. Cell 100:57-70.
12. Harold LM, Edmund YY, Jennifer AP. 1990. TGF-b stimulation and inhibition of cell proliferation. Cell 63(2):245-247.
13. Karsdal MA, Larsen L, Engsig MT, Lou H, Ferreras M, Lochter A, Delaissé JM, Foged NT. 2002. Matrix metalloproteinase-dependent activation of latent transforming growth factor-b controls the conversion of osteoblasts into osteocytes by blocking osteoblast apoptosis. J Biol Chem 277(46):44061-44067.
14. Kitamura T, Tange T, Terasawa T, Chiba S, Kuwaki T, Miyagawa K, Piao YF, Miyazono K, Urabe A, Takaku F. 1989. Establishment and characterization of a unique human cell line that proliferates dependently on GM-CSF, IL-3, or eryth-ropoietin. J Cell Physiol 140(2):323-334.
15. Like B, Massagué J. 1986. The antiproliferative effect of type beta transforming growth factor occurs at a level distal from receptors for growth-activating factors. J Biol Chem 261:13426-13429.
16. Markowitz SD, Roberts AB. 1996. Tumor suppressor activity of the TGF-b pathway in human cancers. Cytokine Growth Factor Rev 7:93-102.
17. Massague J. 1990. The transforming growth factor-beta family. Annu Rev Cell Biol 6:597-641.
18. Massagué J, Wotton D. 2000. Transcriptional control by the TGF-beta/Smad signaling system. EMBO 19:1745-1754.
19. Moses HL, Branum EL, Proper JA, Robinson RA. 1981. Transforming growth factor production by chemically transformed cells. Cancer Res 41:2842-2848.
20. Moustakas A, Pardali K, Gaal A, Heldin CH. 2002. Mechanism of TGF-b signaling in regulation of cell growth and differentiation. Immunol Lett 82:85-91.
21. Randall LA, Wadhwa M, Thorpe R, Mire-Sluis AR. 1993. A novel, sensitive bioassay for transforming growth factor b. J Immunol Methods 164:61-67.
22. Platten M, Wick W, Weller M. 2001. Malignant glioma biology: role for TGF-beta in growth, motility, angiogenesis, and immune escape. Microsc Res Tech 52(4):401-410.
23. Wang M, Zhao D, Spinetti G, Zhang J, Jiang LQ, Pintus G, Monticone R, Lakatta EG. 2006. Matrix metalloproteinase 2 activation of transforming growth factor-b1 and TGF-b1-type II receptor signaling within the aged arterial wall. Arterioscler Thromb Vasc Biol 26:1503-1509.